0001415889-22-006712.txt : 20220617
0001415889-22-006712.hdr.sgml : 20220617
20220617161110
ACCESSION NUMBER: 0001415889-22-006712
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220616
FILED AS OF DATE: 20220617
DATE AS OF CHANGE: 20220617
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KELER TIBOR
CENTRAL INDEX KEY: 0001429931
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-15006
FILM NUMBER: 221023910
MAIL ADDRESS:
STREET 1: 30 PARK ROAD
CITY: OTTSVILLE
STATE: PA
ZIP: 18942
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Celldex Therapeutics, Inc.
CENTRAL INDEX KEY: 0000744218
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 133191702
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 53 FRONTAGE ROAD
STREET 2: SUITE 220
CITY: HAMPTON
STATE: NJ
ZIP: 08827
BUSINESS PHONE: 908-200-7500
MAIL ADDRESS:
STREET 1: 53 FRONTAGE ROAD
STREET 2: SUITE 220
CITY: HAMPTON
STATE: NJ
ZIP: 08827
FORMER COMPANY:
FORMER CONFORMED NAME: AVANT IMMUNOTHERAPEUTICS INC
DATE OF NAME CHANGE: 19980828
FORMER COMPANY:
FORMER CONFORMED NAME: T CELL SCIENCES INC
DATE OF NAME CHANGE: 19920703
4
1
form4-06172022_010651.xml
X0306
4
2022-06-16
0000744218
Celldex Therapeutics, Inc.
CLDX
0001429931
KELER TIBOR
C/O CELLDEX THERAPEUTICS, INC.
53 FRONTAGE ROAD, SUITE 220
HAMPTON
NJ
08827
false
true
false
false
EXECUTIVE VP & CSO
Incentive Stock Option (right to buy)
22.48
2022-06-16
4
A
0
91000
0
A
2023-06-16
2032-06-16
Common Stock
91000
91000
D
Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan.
25% vest on June 16, 2023 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters.
/s/ Samuel B. Martin, attorney-in-fact for Tibor Keler
2022-06-17